Impact Biomedical (IBO) Accumulated Expenses (2022 - 2026)
Impact Biomedical's Accumulated Expenses was $248,000 in Q2 2026, down 6.8% from $266,000 a year earlier but up 18.1% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Impact Biomedical came in at $194,000, unchanged from FY2024.
- Accumulated Expenses shows a three-year compound annual growth rate of 45.5% (FY2022 to FY2025).
- In earlier years, Accumulated Expenses was $194,000 in FY2024 (-15.7%), $230,000 in FY2023 (+265.1%) and $63,000 in FY2022.
- Quarterly Accumulated Expenses has moved between $6,000 (Q3 2023) and $336,000 (Q3 2025) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in three of the last seven quarters, with growth averaging 128.8%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q1 2025 (growth of 361.7%); the worst was Q4 2024 (a decline of 15.7%).
- Per Business Quant data, IBO's Accumulated Expenses in the three quarters before Q2 2026 was $210,000 (Q1 2026), $194,000 (Q4 2025) and $336,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,143.62 Bn | 1,112.20 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.32 Bn | 555.18 Bn | 17.30 Bn |
| 3 | AbbVie | 501.71 Bn | 474.82 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.42 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.80 Bn | 264.79 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.31 Bn | 237.00 Bn | 12.86 Bn |
| 7 | Amgen | 238.70 Bn | 194.10 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.80 Bn | 169.00 Bn | 6.22 Bn |
| 9 | Pfizer | 170.88 Bn | 117.53 Bn | 10.94 Bn |
| 10 | Impact Biomedical | 397.86 Mn | 397.82 Mn | 2,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 248,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 266,000.00 |
| Mar 31, 2025 | 217,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Dec 31, 2022 | 63,000.00 |
API Access
Impact Biomedical Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();